Inhibition of carrageenin-induced paw edema by a superoxide dismutase derivative that circulates bound to albumin.
Although the possible involvement of superoxide radical and its metabolite(s) in the pathogenesis of various types of edema have been suggested, direct evidence supporting this concept is lacking. Since intravenously administered Cu2+Zn2(+)-type superoxide dismutase (SOD) rapidly disappeared from the circulation with a half-life of 4 min, the enzyme could not be used to test whether superoxide radicals played a critical role in the modulation of vascular permeability. We previously synthesized a SOD derivative (SM-SOD) by linking poly(styrene co-maleic acid butyl ester) (SM) to the enzyme (Ogino, T., Inoue, M., Ando, Y., Awai, M., Maeda, H. and Morino Y. (1988) Int. J. Pept. Protein Res. 32, 1583-1588); SM-SOD circulates bound to albumin with a half-life of 6 h. To test whether superoxide radicals play an important role in the regulation of vascular permeability, the effect of SM-SOD on experimental paw edema was studied in the rat. Subcutaneous injections of carrageenin to the paw rapidly induced local edema by increasing vascular permeability. Intravenous administration of SM-SOD markedly inhibited the carrageenin-induced increase in vascular permeability and suppressed the development of paw edema. In contrast, the same dose of SOD showed no such inhibitory effect. These results suggest that superoxide radical and/or its metabolite(s) might play a critical role in the pathogenesis of carrageenin-induced vasogenic edema.
Ando
Y
Y
Department of Biochemistry, Kumamoto University Medical School, Japan.
Inoue
M
M
Araki
S
S
Morino
Y
Y
D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D005070:Evans Blue / Q000378:metabolism; D005609:Free Radicals; D008297:Male; D008298:Maleates; D009504:Neutrophils / Q000473:pathology; D011137:Polystyrenes / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000378:metabolism; D013482:Superoxide Dismutase / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D013481:Superoxides / Q000378:metabolism
D005609:Free Radicals; D008298:Maleates; D011137:Polystyrenes; D012709:Serum Albumin; D013481:Superoxides; D005070:Evans Blue; C059316:poly(styrene-co-maleic acid)butyl ester; D002351:Carrageenan; D013482:Superoxide Dismutase; C068153:superoxide dismutase-poly(styrene co-maleic acid butyl ester)